Petra Behnen
Medical Lead SMA (Germany), Novartis
Petra Behnen is listed as Medical Lead SMA (Germany), Novartis. Petra spoke at DGN Kongress 2026 (Kongress der Deutschen Gesellschaft für Neurologie) in November 2026 (speaker, “Erkrankungen von Rückenmark, Nerv & Muskel II”). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Petra. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
Sessions at 1 conference
DGN Kongress 2026 (Kongress der Deutschen Gesellschaft für Neurologie) 4 November 2026 – 7 November 2026
- Erkrankungen von Rückenmark, Nerv & Muskel II Speaker · 6 November 2026
Spoke alongside
People who have shared a session with Petra at events on B2DB.
- Christine Klötzer Universitätsmedizin Greifswald 1 shared session
- Basil Darras Boston Children’s Hospital 1 shared session
- Crystal M. Proud 1 shared session
- Denise Dreiseidler Dr. · Novartis Pharma GmbH 1 shared session
- Heinke Geipel Dr. · Novartis Pharma GmbH 1 shared session
- Nicholas E Johnson 1 shared session
- Uta Rager Medical Science Liaison Radioligand Therapy · Novartis 1 shared session
Others from Novartis
- Vas Narasimhan Chief Executive Officer 3 sessions
- Esmeralda Cusati Director, CX, Creative Campaign Touchpoints 2 sessions
- Christian Parker Scientist 1 session
- Jae Hahn Director AI Innovation UX 1 session
- Nicholas Adlard HEOR Therapy Area Head: Cardio, Renal, Metabolic 1 session
- Nicholas Balestrino Executive Director, AI and Innovation Partnerships 1 session
- Samantha Kingdom SVP, Therapy Area Head Immunology, International 1 session
- Sonya Rogerson Head of Legal Transformation 1 session
- Uta Rager Medical Science Liaison Radioligand Therapy 1 session